Answers are grounded in this paper and cite their sources.
Review explores digital twins' applications in pharmaceutical manufacturing, emphasizing benefits and challenges.
The pharmaceutical industry is undergoing a digital transformation through the adoption of Industry 4.0 technologies. Among these innovations, Digital Twin (DT) technology has emerged as a powerful tool for improving manufacturing efficiency, product quality, and regulatory compliance. A digital twin is a virtual representation of a physical system that continuously receives and analyzes real-time data from manufacturing processes. In pharmaceutical manufacturing, digital twins enable process simulation, predictive maintenance, quality monitoring, risk assessment, and process optimization. This review discusses the concept, architecture, applications, benefits, challenges, and future prospects of digital twins in pharmaceutical manufacturing and quality assurance.
No takes yet. Share an insight, caveat, or question.
Shelake et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: